483
Diasol, IncFDA 483 - Diasol, Inc - June 28, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected Diasol, Inc., a medical device manufacturer in Phoenix, AZ, from June 7-28, 2021. The inspection revealed significant deficiencies in the firm's quality system, including failures to document corrective and preventive actions, maintain device history records, perform quality audits, and conduct regular management reviews. These issues indicate a lack of control over critical quality processes.
Open in Dashboard
ID · 789f4a22-f0b9-4dba-a6a7-273a1e1c58c2